Diabetes 52:1441-1448, 2003
© 2003 by the American Diabetes Association, Inc.
Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice
Melpomeni Peppa1,
Cijiang He1,
Masakazu Hattori2,
Robert McEvoy1,
Feng Zheng1, and
Helen Vlassara1
1 Division of Experimental Diabetes and Aging, Department of Geriatrics, Mount Sinai School of Medicine, New York, New York
2 Joslin Diabetes Center, Boston, Massachusetts
Advanced glycation end products (AGEs) are implicated in ß-cell oxidant stress. Diet-derived AGE (dAGE) are shown to contribute to end-organ toxicity attributed to diabetes. To assess the role of dAGE on type 1 diabetes, NOD mice were exposed to a high-AGE diet (H-AGE) and to a nutritionally similar diet with approximate fivefold-lower levels of N -carboxymethyllysine (CML) and methylglyoxal-derivatives (MG) (L-AGE). Suppression of serum CML and MG in L-AGE-fed mice was marked by suppression of diabetes (H-AGE mice >94% vs. L-AGE mice 33% in founder [F]0, 14% in F1, and 13% in F2 offspring, P < 0.006) and by a delay in disease onset (4-month lag). Survival for L-AGE mice was 76 vs. 0% after 44 weeks of H-AGE mice. Reduced insulitis in L-AGE versus H-AGE mice (P < 0.01) was marked by GAD- and insulin-unresponsive pancreatic interleukin (IL)-4-positive CD4+ cells compared with the GAD- and insulin-responsive interferon (IFN)- -positive T-cells from H-AGE mice (P < 0.005). Splenocytes from L-AGE mice consisted of GAD- and insulin-responsive IL-10-positive CD4+ cells compared with the IFN- -positive T-cells from H-AGE mice (P < 0.005). Therefore, high AGE intake may provide excess antigenic stimulus for T-cell-mediated diabetes or direct ß-cell injury in NOD mice; both processes are ameliorated by maternal or neonatal exposure to L-AGE nutrition.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Uribarri, W. Cai, M. Peppa, S. Goodman, L. Ferrucci, G. Striker, and H. Vlassara
Circulating Glycotoxins and Dietary Advanced Glycation Endproducts: Two Links to Inflammatory Response, Oxidative Stress, and Aging
J. Gerontol. A Biol. Sci. Med. Sci.,
April 1, 2007;
62(4):
427 - 433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E.B. Reusch
Diabetes and Advanced Glycoxidation End Products.
Diabetes Care,
June 1, 2006;
29(6):
1420 - 1432.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Sandu, K. Song, W. Cai, F. Zheng, J. Uribarri, and H. Vlassara
Insulin Resistance and Type 2 Diabetes in High-Fat-Fed Mice Are Linked to High Glycotoxin Intake
Diabetes,
August 1, 2005;
54(8):
2314 - 2319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. VLASSARA
Advanced Glycation in Health and Disease: Role of the Modern Environment
Ann. N.Y. Acad. Sci.,
June 1, 2005;
1043(1):
452 - 460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. URIBARRI, W. CAI, O. SANDU, M. PEPPA, T. GOLDBERG, and H. VLASSARA
Diet-Derived Advanced Glycation End Products Are Major Contributors to the Body's AGE Pool and Induce Inflammation in Healthy Subjects
Ann. N.Y. Acad. Sci.,
June 1, 2005;
1043(1):
461 - 466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. SEBEKOVA, T. HOFMANN, P. BOOR, K. SEBEKOVA JR., O. ULICNA, H. F. ERBERSDOBLER, J. W. BAYNES, S. R. THORPE, A. HEIDLAND, and V. SOMOZA
Renal Effects of Oral Maillard Reaction Product Load in the Form of Bread Crusts in Healthy and Subtotally Nephrectomized Rats
Ann. N.Y. Acad. Sci.,
June 1, 2005;
1043(1):
482 - 491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, S. S. Yan, J. Colgan, H.-P. Zhang, J. Luban, A. M. Schmidt, D. Stern, and K. C. Herold
Blockade of Late Stages of Autoimmune Diabetes by Inhibition of the Receptor for Advanced Glycation End Products
J. Immunol.,
July 15, 2004;
173(2):
1399 - 1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Peppa, H. Brem, P. Ehrlich, J.-G. Zhang, W. Cai, Z. Li, A. Croitoru, S. Thung, and H. Vlassara
Adverse Effects of Dietary Glycotoxins on Wound Healing in Genetically Diabetic Mice
Diabetes,
November 1, 2003;
52(11):
2805 - 2813.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|